NCT01453244已完成不适用
Pharmacogenomic Research for Prediction of Drug Response in Korean Patients With Hepatitis C
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 373
- 试验地点
- 1
- 主要终点
- Sustained virological response (SVR)
研究概览
简要总结
The aim of this study is to investigate the relationships between drug response and the host genetic factors, viral factors and clinical factors in chronic hepatitis C patients (HCV). And thus, the investigators are trying to develop the pharmacogenomic guideline in the Korean patients with HCV.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hepatitis C virus infected patients
排除标准
- •Patients who infected Hepatitis B virus or Human immunodeficiency virus
- •HCV infected patients previously treated with antiviral drugs
- •Patients had a history of autoimmune hemolytic anemia
结局指标
主要结局
Sustained virological response (SVR)
时间窗: 24 weeks after the end of treatment
Undetectable HCV RNA in serum ( \<15 IU/ml ) 24 weeks after the end of treatment
次要结局
- Anemia(4 weeks after start of treatment)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"Carcinoma, Non-Small-Cell LungNCT00222404University Hospital, Grenoble556
已完成
不适用
The Implementation of Pharmacogenomics Into Primary Care in British ColumbiaPharmacogeneticsNCT02383290University of British Columbia190
已完成
不适用
Pharmacogenetic and Pharmacokinetic Study of ClopidogrelCoronary Artery DiseaseNCT01968499The First Affiliated Hospital with Nanjing Medical University1,805
已完成
不适用
Pharmacogenetic Variation: Factors That May Affect the Efficacy and Safety of Medical MarijuanaNew York Medical Marijuana Program Qualifying ConditionsNCT04083261Columbia Care Inc.157
已完成
不适用
Pharmacogenetics of Warfarin Induction and InhibitionHealthyNCT01447511University of Minnesota39